Skip to Content

ER ER (Erythromycin delayed-release 250 mg (erythromycin base))

Pill imprint ER ER has been identified as Erythromycin delayed-release 250 mg (erythromycin base).

Erythromycin is used in the treatment of dental abscess; skin or soft tissue infection; upper respiratory tract infection; bronchitis; nongonococcal urethritis (and more), and belongs to the drug class macrolides. There is no proven risk in humans during pregnancy. Erythromycin 250 mg (erythromycin base) is not a controlled substance under the Controlled Substance Act (CSA).

Erythromycin delayed-release 250 mg (erythromycin base) ER ER
Discount Card Promo
Erythromycin delayed-release
Imprint:
ER ER
Strength:
250 mg (erythromycin base)
Color:
Pink / Red
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Macrolides
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Arbor Pharmaceuticals, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide